Drawing for WHERE MIRACLES BEGIN

USPTO serial 85961136

WHERE MIRACLES BEGIN

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
Examiner
DUBOIS, MICHELLE
Law office
TMEG LAW OFFICE 107

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WHERE MIRACLES BEGIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erin B. Roth

Erin B. Roth Fulbright & Jaworski LLP2200 Ross Avenue, Suite 2800Dallas, TX 75201-2784UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Human fertility treatment services; Medical services; Medical evaluation, treatment and diagnosis of infertilityACTIVEOct 15, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2013MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Sep 26, 2013ABN1ABANDONMENT - EXPRESS MAILED
Sep 25, 2013EXARTEAS EXPRESS ABANDONMENT RECEIVED
Sep 25, 2013DOCKASSIGNED TO EXAMINER
Sep 5, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2013NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance